Sanochemia has extended production and supply contracts with Janssen N.V., an arm of the US pharma giant Johnson&Johnson. So far Sanochemia had been exclusive producer of an Alzheimer drug component. The contract value was EUR 6 million (USD 6.5 million) p.a.